According to the letter sent to all the ERN Coordinators by Andrzej Rys (Director responsible for health systems, medical products and innovation Directorate-General for Health and Food Safety, European Commission), we would like to draw your attention to the difference between the purposes behind the two primary information systems provided for use by the European Reference Networks.
MetabERN held its first meeting with Patient and Family Associations on the 13th of January 2018.
CDG & Allies - PPAIN are very pleased to inform the lauch of the 4th edition of the Liliana Scientific Initiation Scholarship.
We were deeply saddened to hear that the brave and inspiring Christine Lavery passed away on Tuesday 19th December 2017 in hospital surrounded by her family, following a brief illness. Christine has played an outstanding role in our Lysosomal storage diseases community and for the entire field of rare inherited diseases.
Funding transnational collaborative research through joint transnational calls is one of the major objectives of E-Rare. This is the most important and effective joint activity to enhance the cooperation between European scientists working on rare diseases and thus reducing the fragmentation of research in this field. E-Rare launches calls on a yearly basis. The topic […]
The Innovative Medicines Initiative has now launched IMI2 – Call 13 with the following topics: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches Genome-environment interactions in inflammatory skin disease The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use Mitochondrial dysfunction in neurodegeneration Support and coordination action for the projects in the neurodegeneration area of […]
The European Commission (DG SANTE), on November 20th 2017, launched the First Clinical Patient Management System. It’s a web-based application aimed at supporting ERNs in improving the diagnosis and treatment of rare or low prevalence complex diseases across national borders of Member States in Europe. By providing tools for collaboration and virtual consultations CPMS enables […]
The 20th anniversary edition of the EHFG took place 4-6 October 2017 in Bad Hofgastein, Austria, gathering over 500 participants. The EHFG is the most important health-related event in the European Union and a meeting point for experts from different fields within the health system. Different knowledge and different experiences are brought together to the […]
We are currently recruiting PMM2-CDG patients of all ages for an observational clinical study (GLY-000). This is the first time PMM2-CDG patients will be studied in a multi-center, multi-national group. To be clear: none of the patients in this study will receive an investigational drug. This is only an observational study, but the results are […]
On behalf of our Priority Setting Partnership, I would like to share our questionnaire to set research priorities for liver GSD: http://tiny.cc/IGSD-English Let us know where you think research should be directed in the future. It will take just 5 minutes to complete and is open to anyone with a personal or professional connection to […]